{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:50:16Z","timestamp":1791687016902,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T02:34:16Z","timestamp":1665714856000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes"],"prefix":"10.1016","volume":"352","author":[{"given":"Kamila Bohne","family":"Japiassu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn\u00e8s","family":"Louaguenouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cailleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chapron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tsapis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Leite","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Martins","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Fattal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.10.006_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0777-0","article-title":"Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state","volume":"19","author":"Mitsi","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0010","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1021\/bm5011382","article-title":"Effect of surface modification and macrophage phenotype on particle internalization","volume":"15","author":"Wang","year":"2014","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09059180.05.00009501","article-title":"Lung defences: an overview","volume":"14","author":"Nicod","year":"2005","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0025","first-page":"466","article-title":"Cilia and mucociliary clearance","author":"Ostrowski","year":"2006","journal-title":"Encycl. Respir. Med. Four-Vol. Set."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0030","doi-asserted-by":"crossref","first-page":"105795","DOI":"10.1016\/j.intimp.2019.105795","article-title":"Potential role of M2 macrophage polarization in ventilator-induced lung fibrosis","volume":"75","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0522-0","article-title":"Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity","volume":"18","author":"Bazzan","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0050","article-title":"Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance","volume":"56","author":"Mehta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00435","article-title":"Role of alveolar macrophages in chronic obstructive pulmonary disease","volume":"5","author":"Vlahos","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0060","first-page":"481","article-title":"Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges, Asian","volume":"10","author":"Lee","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0070","first-page":"237","article-title":"Nanodelivery in airway diseases: challenges and therapeutic applications, nanomedicine nanotechnology","volume":"6","author":"Roy","year":"2010","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S4937","article-title":"Nanomedicine in pulmonary delivery","volume":"4","author":"Mansour","year":"2009","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0090","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2010.0838","article-title":"Pulmonary formulations: what remains to be done?","volume":"23","author":"Weers","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0095","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2174\/1389450115666141114152713","article-title":"Targeted drug delivery systems for lung macrophages","volume":"16","author":"Costa","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0105","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2217\/nnm-2016-5000","article-title":"Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs","volume":"11","author":"Nascimento","year":"2016","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0885328219863291","article-title":"Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs","volume":"34","author":"Almeida","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/bc5004313","article-title":"Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells","volume":"26","author":"Alshaer","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2015.10.044","article-title":"Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin","volume":"220","author":"Arabi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2013.06.003","article-title":"Hyaluronic acid-coated liposomes for active targeting of gemcitabine","volume":"85","author":"Arpicco","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0130","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.biomaterials.2009.04.012","article-title":"Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors","volume":"30","author":"McNeeley","year":"2009","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0135","first-page":"1","article-title":"PEGylated \u201cstealth\u201d nanoparticles and liposomes","author":"Shen","year":"2018","journal-title":"Eng. Biomater. Drug Deliv. Syst. Beyond Polyethyl. Glycol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0140","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.3390\/ijms22147743","article-title":"Liposomes loaded with everolimus and coated with hyaluronic acid: a promising approach for lung fibrosis","volume":"22","author":"Pandolfi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/08982100903347923","article-title":"Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation","volume":"20","author":"Jaafar-Maalej","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0150","series-title":"LPS-Induced Lung Inflammation in Vivo (LPS)-Binding Protein Inhibits the Pulmonary Lipopolysaccharide tom Van der Poll","author":"Knapp","year":"2021"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0155","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/17435390.2015.1054908","article-title":"Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles","volume":"10","author":"Aragao-Santiago","year":"2016","journal-title":"Nanotoxicology."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0160","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.colsurfb.2017.06.029","article-title":"Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate","volume":"158","author":"Cosco","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/860780","article-title":"Lipid-based nanovectors for targeting of CD44-overexpressing tumor cells","volume":"2013","author":"Arpicco","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2020.578008","article-title":"Effects of the molecular weight of hyaluronic acid in a carbon nanotube drug delivery conjugate","volume":"8","author":"Arpicco","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0180","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/molecules24183291","article-title":"Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells","volume":"24","author":"Pandolfi","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2014.05.027","article-title":"Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting","volume":"471","author":"Tiantian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0195","first-page":"334","article-title":"Correlating lipid bilayer fluidity with sensitivity and resolution of polytopic membrane protein spectra by solid-state NMR spectroscopy","volume":"2015","author":"Banigan","year":"1848","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0200","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1529\/biophysj.106.084368","article-title":"Comparative calorimetric and spectroscopic studies of the effects of lanosterol and cholesterol on the thermotropic phase behavior and organization of dipalmitoylphosphatidylcholine bilayer membranes","volume":"91","author":"Mannock","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0205","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.bpj.2018.04.003","article-title":"DPPC bilayers in solutions of high sucrose content","volume":"114","author":"Morandi","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.201601012","article-title":"The CD44-mediated uptake of hyaluronic acid-based carriers in macrophages","volume":"6","author":"Rios de la Rosa","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0215","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The Polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0220","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio\u2013nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/bc9801124","article-title":"Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies","volume":"10","author":"Gabizon","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0230","doi-asserted-by":"crossref","first-page":"43550","DOI":"10.1074\/jbc.M308199200","article-title":"Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments","volume":"278","author":"Takeda","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1026425519497","article-title":"CD44 expression and hyaluronic acid binding of malignant glioma cells","volume":"17","author":"Kn\u00fcpfer","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0240","series-title":"Models to Evaluate the Barrier Properties of Mucus During Drug Diffusion","volume":"599","author":"Liu","year":"2021"},{"key":"10.1016\/j.jconrel.2022.10.006_bb0245","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4049\/jimmunol.0901089","article-title":"Alveolar macrophages transport pathogens to lung draining lymph nodes","volume":"183","author":"Kirby","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0250","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3389\/fimmu.2019.02275","article-title":"Editorial: alveolar macrophages in lung inflammation and resolution","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1004","article-title":"Innate immune sensing and its roots: the story of endotoxin","volume":"3","author":"Beutler","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12121222","article-title":"Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases","volume":"12","author":"Su","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.10.006_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/17476348.2020.1820329","article-title":"Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review","volume":"15","author":"Montenegro","year":"2021","journal-title":"Expert. Rev. Respir. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922006769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:29:06Z","timestamp":1759163346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922006769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"alternative-id":["S0168365922006769"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}